IQVIA Holdings (IQV)
173.40
-5.77 (3.22%)
Upcoming Events
Latest Headlines
Morgan Stanley favors Charles River Over IQVIA in CRO sector reset
June 17, 2026 8:47 AM - StreetInsider
Morgan Stanley Downgrades IQVIA Holdings (IQV) to Equalweight
June 17, 2026 6:29 AM - StreetInsider
Morgan Stanley Upgrades Charles River Labs (CRL) to Overweight, 'strong uptick in biopharma funding beginning to transition into RFPs and bookings'
June 17, 2026 6:29 AM - StreetInsider
Wiley and IQVIA Release Cross-Sector Report on AI’s Promise and Pressure Points Across Healthcare Value Chain
June 15, 2026 9:00 AM - BizWire
Form 8-K IQVIA HOLDINGS INC. For: Jun 11
June 11, 2026 4:47 PM - SEC Filing
Morgan Stanley tracks prescription trends for US neurology drugs
June 5, 2026 8:59 AM - StreetInsider
RBC Capital: 'Miebo remains the second-largest Rx DED drug in the US with 22.8% market share'
June 5, 2026 8:49 AM - StreetInsider
Form 8-K IQVIA HOLDINGS INC. For: Jun 04
June 4, 2026 5:08 PM - SEC Filing
IQVIA prices €950 million senior notes due 2033
June 4, 2026 10:51 AM - StreetInsider
IQVIA Announces Pricing of Senior Notes
June 4, 2026 10:51 AM - BizWire
Form 8-K IQVIA HOLDINGS INC. For: Jun 03
June 3, 2026 4:45 PM - SEC Filing
IQVIA Holdings (IQV) PT Lowered to $210 at HSBC
June 3, 2026 5:12 AM - StreetInsider
IQVIA announces €950 million senior notes offering due 2033
June 3, 2026 2:53 AM - StreetInsider
IQVIA Announces Offering of Senior Notes
June 3, 2026 2:53 AM - BizWire
Jefferies finds AI drives up to 50% cost cuts in drug development
June 2, 2026 12:32 PM - StreetInsider
FDA issues draft guidance to reduce animal testing for cancer drugs
May 29, 2026 9:51 AM - StreetInsider
IQVIA CEO to Speak at Jefferies Global Healthcare Conference
May 26, 2026 4:15 PM - BizWire
IQVIA expands partnership with Kexing Biopharm for biosimilar development
May 13, 2026 4:30 PM - StreetInsider
IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities
May 13, 2026 4:30 PM - BizWire
Form 4 IQVIA HOLDINGS INC. For: May 07 Filed by: Wims Morris Leslie
May 11, 2026 5:08 PM - SEC Filing
Form 4 IQVIA HOLDINGS INC. For: May 07 Filed by: GOGGINS COLLEEN A
May 11, 2026 5:08 PM - SEC Filing
Form 4 IQVIA HOLDINGS INC. For: May 07 Filed by: Fasano Jim
May 11, 2026 5:07 PM - SEC Filing
Form 4 IQVIA HOLDINGS INC. For: May 07 Filed by: DANHAKL JOHN G
May 11, 2026 5:06 PM - SEC Filing
Form 8-K IQVIA HOLDINGS INC. For: May 07
May 7, 2026 5:25 PM - SEC Filing
IQVIA board approves $2 billion increase in share repurchase program
May 7, 2026 5:15 PM - StreetInsider
IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization
May 7, 2026 5:15 PM - BizWire
IQVIA Holdings (IQV) PT Lowered to $225 at Morgan Stanley
May 7, 2026 9:01 AM - StreetInsider
IQVIA CFO to Speak at Bank of America Health Care Conference 2026
May 6, 2026 4:15 PM - BizWire
Form 10-Q IQVIA HOLDINGS INC. For: Mar 31
May 5, 2026 4:43 PM - SEC Filing
IQVIA Holdings (IQV) Tops Q1 EPS by 8c ; Offers Guidance
May 5, 2026 7:09 AM - StreetInsider
Form 8-K IQVIA HOLDINGS INC. For: May 05
May 5, 2026 7:04 AM - SEC Filing
IQVIA Reports First-Quarter 2026 Results
May 5, 2026 7:00 AM - BizWire
IQVIA Holdings (IQV) PT Lowered to $210 at BMO Capital into earnings
May 1, 2026 9:38 AM - StreetInsider
Form SCHEDULE 13G IQVIA HOLDINGS INC. Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 30, 2026 11:13 AM - SEC Filing
Form 4 IQVIA HOLDINGS INC. For: Apr 23 Filed by: Stamps Sheila A
April 27, 2026 5:05 PM - SEC Filing
Form 4 IQVIA HOLDINGS INC. For: Apr 23 Filed by: Wims Morris Leslie
April 27, 2026 5:04 PM - SEC Filing
Form 4 IQVIA HOLDINGS INC. For: Apr 23 Filed by: Kaelin William G Jr
April 27, 2026 5:04 PM - SEC Filing
Form 4 IQVIA HOLDINGS INC. For: Apr 23 Filed by: LEONARD JOHN M
April 27, 2026 5:03 PM - SEC Filing
Form 4 IQVIA HOLDINGS INC. For: Apr 23 Filed by: GOGGINS COLLEEN A
April 27, 2026 5:03 PM - SEC Filing
Form 4 IQVIA HOLDINGS INC. For: Apr 23 Filed by: DANHAKL JOHN G
April 27, 2026 5:02 PM - SEC Filing
Form 4 IQVIA HOLDINGS INC. For: Apr 23 Filed by: Fasano Jim
April 27, 2026 5:02 PM - SEC Filing
Form 4 IQVIA HOLDINGS INC. For: Apr 23 Filed by: Burt Carol
April 27, 2026 5:00 PM - SEC Filing
Morgan Stanley Comments on Eli Lilly (LLY) Amid Premarket Volatility
April 24, 2026 7:27 AM - StreetInsider
Form S-8 IQVIA HOLDINGS INC.
April 23, 2026 7:12 PM - SEC Filing
Form 8-K IQVIA HOLDINGS INC. For: Apr 23
April 23, 2026 7:10 PM - SEC Filing
IQVIA to Announce First-Quarter 2026 Results on May 5, 2026
April 15, 2026 4:15 PM - BizWire
IQVIA Holdings (IQV) PT Lowered to $185 at Evercore ISI
April 8, 2026 9:08 AM - StreetInsider
Form SCHEDULE 13G/A IQVIA HOLDINGS INC. Filed by: VANGUARD GROUP INC
March 27, 2026 9:54 AM - SEC Filing
Full Article List
